Identification of anti-virulence compounds that disrupt quorum-sensing regulated acute and persistent pathogenicity.
Etiological agents of acute, persistent, or relapsing clinical infections are often refractory to antibiotics due to multidrug resistance and/or antibiotic tolerance. Pseudomonas aeruginosa is an opportunistic Gram-negative bacterial pathogen that causes recalcitrant and severe acute chronic and per...
Guardado en:
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9aa02961081547b7bbda3bdbbafe6365 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:9aa02961081547b7bbda3bdbbafe6365 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:9aa02961081547b7bbda3bdbbafe63652021-11-25T05:46:09ZIdentification of anti-virulence compounds that disrupt quorum-sensing regulated acute and persistent pathogenicity.1553-73661553-737410.1371/journal.ppat.1004321https://doaj.org/article/9aa02961081547b7bbda3bdbbafe63652014-08-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25144274/pdf/?tool=EBIhttps://doaj.org/toc/1553-7366https://doaj.org/toc/1553-7374Etiological agents of acute, persistent, or relapsing clinical infections are often refractory to antibiotics due to multidrug resistance and/or antibiotic tolerance. Pseudomonas aeruginosa is an opportunistic Gram-negative bacterial pathogen that causes recalcitrant and severe acute chronic and persistent human infections. Here, we target the MvfR-regulated P. aeruginosa quorum sensing (QS) virulence pathway to isolate robust molecules that specifically inhibit infection without affecting bacterial growth or viability to mitigate selective resistance. Using a whole-cell high-throughput screen (HTS) and structure-activity relationship (SAR) analysis, we identify compounds that block the synthesis of both pro-persistence and pro-acute MvfR-dependent signaling molecules. These compounds, which share a benzamide-benzimidazole backbone and are unrelated to previous MvfR-regulon inhibitors, bind the global virulence QS transcriptional regulator, MvfR (PqsR); inhibit the MvfR regulon in multi-drug resistant isolates; are active against P. aeruginosa acute and persistent murine infections; and do not perturb bacterial growth. In addition, they are the first compounds identified to reduce the formation of antibiotic-tolerant persister cells. As such, these molecules provide for the development of next-generation clinical therapeutics to more effectively treat refractory and deleterious bacterial-human infections.Melissa StarkeyFrancois LepineDamien MauraArunava BandyopadhayaBiljana LesicJianxin HeTomoe KitaoValeria RighiSylvain MilotAria TzikaLaurence RahmePublic Library of Science (PLoS)articleImmunologic diseases. AllergyRC581-607Biology (General)QH301-705.5ENPLoS Pathogens, Vol 10, Iss 8, p e1004321 (2014) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Immunologic diseases. Allergy RC581-607 Biology (General) QH301-705.5 |
spellingShingle |
Immunologic diseases. Allergy RC581-607 Biology (General) QH301-705.5 Melissa Starkey Francois Lepine Damien Maura Arunava Bandyopadhaya Biljana Lesic Jianxin He Tomoe Kitao Valeria Righi Sylvain Milot Aria Tzika Laurence Rahme Identification of anti-virulence compounds that disrupt quorum-sensing regulated acute and persistent pathogenicity. |
description |
Etiological agents of acute, persistent, or relapsing clinical infections are often refractory to antibiotics due to multidrug resistance and/or antibiotic tolerance. Pseudomonas aeruginosa is an opportunistic Gram-negative bacterial pathogen that causes recalcitrant and severe acute chronic and persistent human infections. Here, we target the MvfR-regulated P. aeruginosa quorum sensing (QS) virulence pathway to isolate robust molecules that specifically inhibit infection without affecting bacterial growth or viability to mitigate selective resistance. Using a whole-cell high-throughput screen (HTS) and structure-activity relationship (SAR) analysis, we identify compounds that block the synthesis of both pro-persistence and pro-acute MvfR-dependent signaling molecules. These compounds, which share a benzamide-benzimidazole backbone and are unrelated to previous MvfR-regulon inhibitors, bind the global virulence QS transcriptional regulator, MvfR (PqsR); inhibit the MvfR regulon in multi-drug resistant isolates; are active against P. aeruginosa acute and persistent murine infections; and do not perturb bacterial growth. In addition, they are the first compounds identified to reduce the formation of antibiotic-tolerant persister cells. As such, these molecules provide for the development of next-generation clinical therapeutics to more effectively treat refractory and deleterious bacterial-human infections. |
format |
article |
author |
Melissa Starkey Francois Lepine Damien Maura Arunava Bandyopadhaya Biljana Lesic Jianxin He Tomoe Kitao Valeria Righi Sylvain Milot Aria Tzika Laurence Rahme |
author_facet |
Melissa Starkey Francois Lepine Damien Maura Arunava Bandyopadhaya Biljana Lesic Jianxin He Tomoe Kitao Valeria Righi Sylvain Milot Aria Tzika Laurence Rahme |
author_sort |
Melissa Starkey |
title |
Identification of anti-virulence compounds that disrupt quorum-sensing regulated acute and persistent pathogenicity. |
title_short |
Identification of anti-virulence compounds that disrupt quorum-sensing regulated acute and persistent pathogenicity. |
title_full |
Identification of anti-virulence compounds that disrupt quorum-sensing regulated acute and persistent pathogenicity. |
title_fullStr |
Identification of anti-virulence compounds that disrupt quorum-sensing regulated acute and persistent pathogenicity. |
title_full_unstemmed |
Identification of anti-virulence compounds that disrupt quorum-sensing regulated acute and persistent pathogenicity. |
title_sort |
identification of anti-virulence compounds that disrupt quorum-sensing regulated acute and persistent pathogenicity. |
publisher |
Public Library of Science (PLoS) |
publishDate |
2014 |
url |
https://doaj.org/article/9aa02961081547b7bbda3bdbbafe6365 |
work_keys_str_mv |
AT melissastarkey identificationofantivirulencecompoundsthatdisruptquorumsensingregulatedacuteandpersistentpathogenicity AT francoislepine identificationofantivirulencecompoundsthatdisruptquorumsensingregulatedacuteandpersistentpathogenicity AT damienmaura identificationofantivirulencecompoundsthatdisruptquorumsensingregulatedacuteandpersistentpathogenicity AT arunavabandyopadhaya identificationofantivirulencecompoundsthatdisruptquorumsensingregulatedacuteandpersistentpathogenicity AT biljanalesic identificationofantivirulencecompoundsthatdisruptquorumsensingregulatedacuteandpersistentpathogenicity AT jianxinhe identificationofantivirulencecompoundsthatdisruptquorumsensingregulatedacuteandpersistentpathogenicity AT tomoekitao identificationofantivirulencecompoundsthatdisruptquorumsensingregulatedacuteandpersistentpathogenicity AT valeriarighi identificationofantivirulencecompoundsthatdisruptquorumsensingregulatedacuteandpersistentpathogenicity AT sylvainmilot identificationofantivirulencecompoundsthatdisruptquorumsensingregulatedacuteandpersistentpathogenicity AT ariatzika identificationofantivirulencecompoundsthatdisruptquorumsensingregulatedacuteandpersistentpathogenicity AT laurencerahme identificationofantivirulencecompoundsthatdisruptquorumsensingregulatedacuteandpersistentpathogenicity |
_version_ |
1718414473108127744 |